Cargando…
Clinical and prognostic relevance of CXCL12 expression in acute myeloid leukemia
BACKGROUND: Accumulating studies have been made to understand the association between CXC chemokine ligand-12 (CXCL12)/CXC chemokine receptor 4 (CXCR4) and acute myeloid leukemia (AML). However, large-scale data analysis of potential relationship between CXCL12 and AML remains insufficient. METHODS:...
Autores principales: | Wang, Shi-sen, Xu, Zi-jun, Jin, Ye, Ma, Ji-chun, Xia, Pei-hui, Wen, Xiangmei, Mao, Zhen-wei, Lin, Jiang, Qian, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300536/ https://www.ncbi.nlm.nih.gov/pubmed/34327063 http://dx.doi.org/10.7717/peerj.11820 |
Ejemplares similares
-
Integrated analysis reveals distinct molecular, clinical, and immunological features of B7‐H3 in acute myeloid leukemia
por: Zhang, Ling‐yi, et al.
Publicado: (2021) -
CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma
por: Lin, Tong, et al.
Publicado: (2021) -
Reduced expression of lncRNA DLEU7-AS1 is a novel favorable prognostic factor in acute myeloid leukemia
por: Wang, Cui-zhu, et al.
Publicado: (2022) -
Association of rs1801157 single nucleotide polymorphism of CXCL12 gene in breast cancer in Pakistan and in-silico expression analysis of CXCL12–CXCR4 associated biological regulatory network
por: Khalid, Samra, et al.
Publicado: (2017) -
CD37 high expression as a potential biomarker and association with poor outcome in acute myeloid leukemia
por: Zhang, Qi, et al.
Publicado: (2020)